Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Jodi A. McKenzie"'
Autor:
Rina M. Mbofung, Jodi A. McKenzie, Shruti Malu, Min Zhang, Weiyi Peng, Chengwen Liu, Isere Kuiatse, Trang Tieu, Leila Williams, Seram Devi, Emily Ashkin, Chunyu Xu, Lu Huang, Minying Zhang, Amjad H. Talukder, Satyendra C. Tripathi, Hiep Khong, Nikunj Satani, Florian L. Muller, Jason Roszik, Timothy Heffernan, James P. Allison, Gregory Lizee, Sam M. Hanash, David Proia, Rodabe Amaria, R. Eric Davis, Patrick Hwu
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-8 (2017)
Many patients fail to respond to T cell based immunotherapies. Here, the authors, through a high-throughput screening, identify HSP90 inhibitors as a class of preferred drugs for treatment combination with immunotherapy.
Externí odkaz:
https://doaj.org/article/51b2a4e16a0b435cabee2477f3975980
Autor:
Patrick Hwu, Michael A. Davies, Laszlo Radvanyi, Jeffrey E. Gershenwald, Jennifer A. Wargo, Thomas F. Gajewski, Jason Roszik, Gregory Lizée, Willem W. Overwijk, Scott E. Woodman, Marcus W. Bosenberg, Roland L. Bassett, Jianhua Hu, Timothy P. Heffernan, Lawrence N. Kwong, Haiyan S. Li, Tina Cascone, Isabella C. Glitza, Jennifer L. McQuade, Rodabe Amaria, Cara Haymaker, Marie-Andree Forget, Chantale Bernatchez, Xiaoxing Yu, Stefani Spranger, Trang N. Tieu, Pei-Ling Chen, Zachary A. Cooper, Carlos A. Torres-Cabala, Alexander J. Lazar, Rina Mbofung, Guo Chen, Wanleng Deng, Leila J. Williams, Xiaoxuan Liang, Chunlei Zhang, Jodi A. McKenzie, Chunyu Xu, Michael T. Tetzlaff, Caitlin Creasy, Shruti Malu, Chengwen Liu, Jie Qing Chen, Weiyi Peng
PTEN loss in melanoma promotes resistance to T cell-mediated anti-tumor activity in the context of concurrent a selective inhibitor for mutant BRAF.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0277424931532ef4ae329209a163cd6e
https://doi.org/10.1158/2159-8290.22531050
https://doi.org/10.1158/2159-8290.22531050
Autor:
Patrick Hwu, Michael A. Davies, Laszlo Radvanyi, Jeffrey E. Gershenwald, Jennifer A. Wargo, Thomas F. Gajewski, Jason Roszik, Gregory Lizée, Willem W. Overwijk, Scott E. Woodman, Marcus W. Bosenberg, Roland L. Bassett, Jianhua Hu, Timothy P. Heffernan, Lawrence N. Kwong, Haiyan S. Li, Tina Cascone, Isabella C. Glitza, Jennifer L. McQuade, Rodabe Amaria, Cara Haymaker, Marie-Andree Forget, Chantale Bernatchez, Xiaoxing Yu, Stefani Spranger, Trang N. Tieu, Pei-Ling Chen, Zachary A. Cooper, Carlos A. Torres-Cabala, Alexander J. Lazar, Rina Mbofung, Guo Chen, Wanleng Deng, Leila J. Williams, Xiaoxuan Liang, Chunlei Zhang, Jodi A. McKenzie, Chunyu Xu, Michael T. Tetzlaff, Caitlin Creasy, Shruti Malu, Chengwen Liu, Jie Qing Chen, Weiyi Peng
Supplementary Table S1. Patient characteristics of the single-agent anti-PD-1 cohort. Supplementary Table S2. List of primers used for gene expression analysis by real-time PCR. Supplementary Table S3. List of autophagy-related genes for overexpressi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bce53f3fe548d08c6e03a55247e9c4b5
https://doi.org/10.1158/2159-8290.22531026
https://doi.org/10.1158/2159-8290.22531026
Autor:
Patrick Hwu, Niranjan Yanamandra, Elaine M. Paul, Roopa Srinivasan, James Smothers, Axel Hoos, Michael A. Davies, Hussein A. Tawbi, Gregory Lizee, Jian Wang, Sara Elizabeth Leahey, Rina M. Mbofung, Kui S. Voo, Heather L. Jackson, Yuan Chen, Jodi A. McKenzie, Brenda Melendez, Chunyu Xu, Leila J. Williams, Weiyi Peng
The cytokine changes in mice receiving PI3K inhibition in combination with anti-OX40 treatment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61f6039acfa1d8709a210d4ff0939de3
https://doi.org/10.1158/1078-0432.22472204.v1
https://doi.org/10.1158/1078-0432.22472204.v1
Autor:
Patrick Hwu, Niranjan Yanamandra, Elaine M. Paul, Roopa Srinivasan, James Smothers, Axel Hoos, Michael A. Davies, Hussein A. Tawbi, Gregory Lizee, Jian Wang, Sara Elizabeth Leahey, Rina M. Mbofung, Kui S. Voo, Heather L. Jackson, Yuan Chen, Jodi A. McKenzie, Brenda Melendez, Chunyu Xu, Leila J. Williams, Weiyi Peng
Supplementary Figure legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fed6dfda111375a3bc5f8f7a1df7f23
https://doi.org/10.1158/1078-0432.22472201.v1
https://doi.org/10.1158/1078-0432.22472201.v1
Autor:
Patrick Hwu, Scott E. Woodman, Gregory Lizée, Jason Roszik, Weiyi Peng, Anil Korkut, Rodabe N. Amaria, Timothy Heffernan, Chantale Bernatchez, Michael A. Davies, Jennifer A. Wargo, Roger S. Lo, Richard Eric Davis, Zhi-Qiang Wang, Rina M. Mbofung, Zhe Wang, Leila J. Williams, Marie-Andrée Forget, Cara Haymaker, Tatiana Karpinets, Trang Tieu, Amjad H. Talukder, Miles C. Andrews, Jodi A. McKenzie, Shruti Malu, Lu Huang
A list of all 384 ORFs in the library
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b585201eba4ae359fcc58f8e4e0579dc
https://doi.org/10.1158/1078-0432.22464129
https://doi.org/10.1158/1078-0432.22464129
Autor:
Patrick Hwu, Niranjan Yanamandra, Elaine M. Paul, Roopa Srinivasan, James Smothers, Axel Hoos, Michael A. Davies, Hussein A. Tawbi, Gregory Lizee, Jian Wang, Sara Elizabeth Leahey, Rina M. Mbofung, Kui S. Voo, Heather L. Jackson, Yuan Chen, Jodi A. McKenzie, Brenda Melendez, Chunyu Xu, Leila J. Williams, Weiyi Peng
Purpose:OX40 agonist–based combinations are emerging as a novel avenue to improve the effectiveness of cancer immunotherapy. To better guide its clinical development, we characterized the role of the OX40 pathway in tumor-reactive immune cells. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21ac271984f7d9259de1b307571c8647
https://doi.org/10.1158/1078-0432.c.6528155.v1
https://doi.org/10.1158/1078-0432.c.6528155.v1
Autor:
Patrick Hwu, Scott E. Woodman, Gregory Lizée, Jason Roszik, Weiyi Peng, Anil Korkut, Rodabe N. Amaria, Timothy Heffernan, Chantale Bernatchez, Michael A. Davies, Jennifer A. Wargo, Roger S. Lo, Richard Eric Davis, Zhi-Qiang Wang, Rina M. Mbofung, Zhe Wang, Leila J. Williams, Marie-Andrée Forget, Cara Haymaker, Tatiana Karpinets, Trang Tieu, Amjad H. Talukder, Miles C. Andrews, Jodi A. McKenzie, Shruti Malu, Lu Huang
Purpose: Cancer immunotherapy has shown promising clinical outcomes in many patients. However, some patients still fail to respond, and new strategies are needed to overcome resistance. The purpose of this study was to identify novel genes and unders
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::299591d297ae07016b995ed637468f62
https://doi.org/10.1158/1078-0432.c.6525624
https://doi.org/10.1158/1078-0432.c.6525624
Autor:
Patrick Hwu, Scott E. Woodman, Gregory Lizée, Jason Roszik, Weiyi Peng, Anil Korkut, Rodabe N. Amaria, Timothy Heffernan, Chantale Bernatchez, Michael A. Davies, Jennifer A. Wargo, Roger S. Lo, Richard Eric Davis, Zhi-Qiang Wang, Rina M. Mbofung, Zhe Wang, Leila J. Williams, Marie-Andrée Forget, Cara Haymaker, Tatiana Karpinets, Trang Tieu, Amjad H. Talukder, Miles C. Andrews, Jodi A. McKenzie, Shruti Malu, Lu Huang
Supplementary figure and table legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5abd5f1d309bef3964bb51693f7a8cf7
https://doi.org/10.1158/1078-0432.22464123
https://doi.org/10.1158/1078-0432.22464123
Supplementary Methods from Survivin Enhances Motility of Melanoma Cells by Supporting Akt Activation and α5 Integrin Upregulation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b7e037b5d29d4f8a30f5edcc211f8e6
https://doi.org/10.1158/0008-5472.22385120
https://doi.org/10.1158/0008-5472.22385120